Key statistics
As of last trade, Arvinas Inc (ARVN:NSQ) traded at 25.93, 23.54% above the 52 week low of 20.99 set on Nov 22, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 25.63 |
---|---|
High | 26.55 |
Low | 25.13 |
Bid | 25.91 |
Offer | 25.98 |
Previous close | 25.11 |
Average volume | 798.35k |
---|---|
Shares outstanding | 68.71m |
Free float | 62.73m |
P/E (TTM) | -- |
Market cap | 1.73bn USD |
EPS (TTM) | -4.79 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 19:10 GMT.
More ▼
Announcements
- Arvinas to Participate in Upcoming Investor Conferences
- Arvinas Reports Third Quarter 2024 Financial Results and Provides Corporate Update
- Arvinas Gives Back to Local Greater New Haven Community in Third Annual Impact Day
- Arvinas to Report Third Quarter 2024 Financial Results and Provide Corporate Update and Host Webcast on Wednesday, October 30, 2024
- Arvinas Reports Second Quarter 2024 Financial Results and Provides Corporate Update
- Arvinas Appoints Andrew Saik as Chief Financial Officer and Treasurer
- Arvinas Announces Presentations for Two of its PROTAC® Investigational Programs Targeting BCL6 and LRRK2
- Arvinas Announces Promotions of Ian Taylor, Ph.D. to President of Research and Development and Angela Cacace, Ph.D. to Chief Scientific Officer
- Arvinas Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Congress
- Arvinas and Pfizer Announce Updated Clinical Data from Phase 1b Trial of Vepdegestrant in Combination with Palbociclib (IBRANCE®)
More ▼